Two years after starting gender-affirming hormone treatments, transgender
and non binary youth experienced a sustained reduction in depression and
anxiety. They also achieved a significantly improved alignment between
their gender and physical characteristics, reports a new study.
The study demonstrates that gender-affirming hormone treatment is valuable
for transgender and non binary adolescents—a group at an elevated risk of
suicidality, depression, and anxiety.The study, from July 2016 through June 2019, included 315 transgender and
nonbinary young people 12 to 20 years of age.
and non binary youth experienced a sustained reduction in depression and
anxiety. They also achieved a significantly improved alignment between
their gender and physical characteristics, reports a new study.
The study demonstrates that gender-affirming hormone treatment is valuable
for transgender and non binary adolescents—a group at an elevated risk of
suicidality, depression, and anxiety.The study, from July 2016 through June 2019, included 315 transgender and
nonbinary young people 12 to 20 years of age.
They were treated by clinics at the Ann and Robert H. Lurie Children’s
Hospital of Chicago, Boston Children’s Hospital, the UCSF Benioff
Children’s Hospitals in the San Francisco area, and Children’s Hospital in
Los Angeles.The study was funded by the Eunice Kennedy Shriver National
Institute of Child Health and Human Development.
